(Q38101167)

28 August 2017

title

Poststroke depression: a review emphasizing the role of prophylactic treatment and synergy with treatment for motor recovery (English)

1 reference

28 August 2017

Murray Flaster

1

1 reference

28 August 2017

Aparna Sharma

series ordinal

2

1 reference

28 August 2017

Murali Rao

series ordinal

3

1 reference

28 August 2017

publication date

1 March 2013

1 reference

Topics in Stroke Rehabilitation

28 August 2017

published in

1 reference

28 August 2017

volume

20

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

139-150

1 reference

Depression after stroke: a prospective epidemiological study

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Functional impairment associated with acute poststroke depression: the Stroke Data Bank Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Post stroke depression: epidemiology, pathophysiology, and biological treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Major depression in stroke patients. A 3-year longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Natural history, predictors, and associations of depression 5 years after stroke: the South London Stroke Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

An efficient way to detect poststroke depression by subsequent administration of a 9-item and a 2-item Patient Health Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Depression is an independent predictor of poor long-term functional outcome post-stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Depressive symptoms and increased risk of stroke mortality over a 29-year period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Depressive symptomatology and hypertension-associated morbidity and mortality in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Mortality and poststroke depression: a placebo-controlled trial of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Mood disorders in stroke patients. Importance of location of lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Comparison of cortical and subcortical lesions in the production of poststroke mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Depression in stroke rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Post-stroke depression and lesion location

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Relationship between anxiety disorders and depressive disorders in patients with cerebrovascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Mood changes in stroke patients: relationship to lesion location

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Depression after stroke and lesion location: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Magnetic resonance imaging correlates of depression after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Stroke lesion in cortical neural circuits and post-stroke incidence of major depressive episode: a 4-month prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Amygdala in stroke/transient ischemic attack patients and its relationship to cognitive impairment and psychopathology: the Sydney Stroke Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Clinically defined vascular depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

'Vascular depression' hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Rates of depression at 3 and 15 months poststroke and their relationship with cognitive decline: the Sydney Stroke Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Coevolution of white matter hyperintensities and cognition in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Progression of Subcortical Ischemic Disease From Vascular Depression to Vascular Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Prospective study of depressive symptoms and risk of stroke among japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Cerebrovascular risk factors and depression in older primary care patients: testing a vascular brain disease model of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Apolipoprotein E genotype and major depression in a community of older adults. The Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Effect of uncertainty on depression in patients with newly diagnosed atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Depression, anxiety, and quality of life in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Single voxel proton magnetic resonance spectroscopy in post-stroke depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Emerging role of glutamate in the pathophysiology of major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Depressive symptoms after stroke and relationship with dementia: A three-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Depressive Symptoms and Risk of Stroke: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

A prospective evaluation of the directionality of the depression-inflammation relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Depression, alterations in platelet function, and ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Arterial endothelial function is impaired in treated depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Enhancement of recovery from psychiatric illness by methylfolate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Personality and vulnerability to depression in stroke patients: a 1-year prospective follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

The Sunnybrook Stroke Study: a prospective study of depressive symptoms and functional outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Early cognitive impairment predicts long-term depressive symptoms and quality of life after stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Poststroke depression and its role in rehabilitation of inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

A prospective study of predictors of poststroke depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

A molecular and cellular theory of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

A neurotrophic model for stress-related mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

The cellular neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

The developmental role of serotonin: news from mouse molecular genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Adult brain neurogenesis and psychiatry: a novel theory of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

5-HT1A receptor antagonist administration decreases cell proliferation in the dentate gyrus

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Fluoxetine targets early progenitor cells in the adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Repairing the human brain after stroke. II. Restorative therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Mechanisms and functional implications of adult neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Evidence for stroke-induced neurogenesis in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Proliferation in the human ipsilateral subventricular zone after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Cellular and molecular mechanisms of neural repair after stroke: making waves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Management of depression after stroke: a systematic review of pharmacological therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Escitalopram and enhancement of cognitive recovery following stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Survival study of vascular dementia in Rochester, Minnesota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

The 2005 Thomas Willis Lecture: stroke and vascular cognitive impairment: a transdisciplinary, translational and transactional approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Prevention of poststroke depression with milnacipran in patients with acute ischemic stroke: a double-blind randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Neuropsychiatric consequences of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Intracranial haemorrhage and use of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

The use of antidepressants and the risk of haemorrhagic stroke: a nested case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of 'vascular depression'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Calcium antagonists for ischemic stroke: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Stroke rehabilitation: recent advances and future therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Safety of pharmacological augmentation of stroke rehabilitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

The efficacy and safety of ECT in depressed older adults: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Cerebral White Matter Lesions and Depressive Symptoms in Elderly Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTSR2002-139

21 January 2018

Identifiers

DOI

10.1310/TSR2002-139

1 reference

28 August 2017

1 reference